耗资近20亿元，衢州市国资委入主东峰集团

Group 1 - Dongfeng Group's stock experienced significant volatility after resuming trading, with a drop of 2.07% on January 22 and a further decline to the daily limit on January 23 [1] - The company announced a control change, with its major shareholder, Hong Kong Dongfeng Investment Group, planning to transfer 29.90% of its shares to Qizhou Zhishang and Qizhou Zhiwei, with total transfer prices of 1.306 billion yuan and 646 million yuan respectively [1][3] - Following the share transfer, Hong Kong Dongfeng Investment's holding will decrease to 16.57%, while Qizhou Zhishang and Qizhou Zhiwei will collectively hold 29.90% of the shares [3] Group 2 - Dongfeng Group's business focus has shifted significantly, with pharmaceutical packaging accounting for a substantial portion of revenue in the first half of 2024, while the revenue from cigarette labels dropped to 10.46% [2][5] - The company is undergoing a strategic transformation, concentrating resources on new material business sectors, particularly in I-type pharmaceutical packaging and medical supplies [6] - The cigarette packaging industry is experiencing a decline due to internal restructuring and competition from self-built packaging factories, prompting traditional companies to seek transformation as a means to improve performance [6] Group 3 - The new controlling entity, Qizhou Zhishang and Qizhou Zhiwei, is backed by Qizhou Industrial Investment Group and Qizhou Industrial Research Institute, with the ultimate controller being the Qizhou State-owned Assets Supervision and Administration Commission [4] - The agreement stipulates that after the 2024 annual report is disclosed, the new controlling shareholders will have the right to nominate several board members, indicating a significant governance change [4] - Dongfeng Group aims to attract high-tech enterprises and promote local industrial development through this transaction, enhancing long-term sustainable growth [6][7]